Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation is a Healthcare company in the S&P 500, with a market capitalization of about $49.8 billion as of October 1, 2026.
- Ticker
- EW · NYSE
- Sector
- Healthcare
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Market cap
- $49.8 billion
- Employees
- 16,000
- Headquarters
- Irvine, CA
- Fiscal year end
- December 31
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Financial statements
Nvevo shows Edwards Lifesciences Corporation's income statement, balance sheet, cash flow statement and key ratios as reported in its 10-K and 10-Q filings with the SEC, annually and quarterly, alongside price history, recent news and fair value models.
Other Healthcare companies
- Eli Lilly and Company (LLY)
- Johnson & Johnson (JNJ)
- AbbVie Inc. (ABBV)
- Merck & Co., Inc. (MRK)
- UnitedHealth Group Incorporated (UNH)
- Thermo Fisher Scientific Inc. (TMO)
- Amgen Inc. (AMGN)
- Gilead Sciences, Inc. (GILD)
Research another company · Market map · Stock screener · Compare companies